Working… Menu

Study of Curcumin, Vorinostat, and Sorafenib

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01608139
Recruitment Status : Withdrawn
First Posted : May 30, 2012
Last Update Posted : October 19, 2012
Sabinsa Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2022
Study Completion Date : No date given